🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Oruka Therapeutics, Inc.

ORKA Healthcare
$81.15 +$1.23 (1.54%)
Market Cap: $5.37 B
Gurus Holding
3
Popularity Rank
#2836
% of Shares Held
2.40%
Net Activity (Q2 2026)
-$102.86 M

Guru Ownership Trend

Guru Analysis for Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $129.03 M.

Top institutional holders include Andreas Halvorsen and Ken Fisher.

Institutional sentiment is currently Bearish. This is evidenced by a $102.86 M net outflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 344.4%. Conversely, Andreas Halvorsen reduced exposure by 43.6%.

Key Holders

Top 5 by Value

$143.09 M
$6.46 M
$1.78 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$7.84 M
Total Buy Value
New Buys 1
Additions 1
-$110.7 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Oruka Therapeutics, Inc. (ORKA)

Major holders include Andreas Halvorsen ($143.09 M), Ken Fisher ($6.46 M), Cliff Asness ($1.78 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.59 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $102.86 M, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ORKA. The total reported sell value was $110.7 M.

Yes, 1 managers opened new positions in ORKA, and 1 increased their existing holdings. The total reported buy value was $7.84 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.41% Reduce -43.6% 1,503,478 $143.09 M Q2 2026
0.00% New Buy 67,874 $6.46 M Q2 2026
0.00% Add 344.4% 18,697 $1.78 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form